LIFESPAN DAILY LOCOMOTOR ACTIVITY RHYTHMS IN A MOUSE MODEL OF AMYLOID-INDUCED NEUROPATHOLOGY

REFERENCES

• Ambree O, Touma C, Gortz N, Keyvani K, Paulus W, Palme R, Sachser N. (2006). Activity changes and marked stereotypic behavior precede Abeta pathology in TgCRND8 Alzheimer mice. Neurobiol. Aging 27:955–964.
   Google Scholar
• Aujard F, Cayetanot F, Bentivoglio M, Perret M. (2006). Age-related effects on the biological clock and its behavioral output in a primate. Chronobiol. Int. 23:451–460.
   PubMed Web of Science ®Google Scholar
• Bateman RJ, Wen S, Morris JC, Holtzman DM. (2007). Fluctuations of CSF amyloid-β levels Implications for a diagnostic and therapeutic biomarker Neurology 68:666–669.
   PubMed Web of Science ®Google Scholar
• Benloucif S, Masana MI, Dubocovich ML. (1997). Light-induced phase shifts of circadian activity rhythms and immediate early gene expression in the suprachiasmatic nucleus are attenuated in old C3H/HeN mice. Brain Res. 747:34–42.
   PubMed Web of Science ®Google Scholar
• Davis FC, Menaker M. (1980). Hamsters through time's window: Temporal structure of hamster locomotor rhythmicity. Am. J. Physiol. 239:R149–R155.
   PubMed Web of Science ®Google Scholar
• Duguay D, Cermakian N. (2009). The crosstalk between physiology and clock proteins. Chronobiol. Int. 26:1479–1513.
   PubMed Web of Science ®Google Scholar
• Duyckaerts C, Delatour B, Potier MC. (2009). Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 118:5–36.
   PubMed Web of Science ®Google Scholar
• Edgar DM, Kilduff TS, Martin CE, Dement WC. (1991a). Influence of running wheel activity on free-running sleep/wake and drinking circadian rhythms in mice. Physiol. Behav. 50:373–378.
   PubMed Web of Science ®Google Scholar
• Edgar DM, Martin CE, Dement WC. (1991b). Activity feedback to the mammalian circadian pacemaker: Influence on observed measures of rhythm period length. J. Biol. Rhythms 6:185–199.
   PubMed Web of Science ®Google Scholar
• Furio AM, Cutrera RA, Castillo TV, Perez LS, Riccio P, Caccuri RL, Brusco LL, Cardinali DP. (2002). Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25–35 in the suprachiasmatic nuclei. Cell. Mol. Neurobiol. 22:699.
   PubMedGoogle Scholar
• Gil-Bea FJ, Aisa B, Schliebs R, Ramirez MJ. (2007). Increase of locomotor activity underlying the behavioral disinhibition in tg2576 mice. Behav. Neurosci. 121:340–344.
   PubMed Web of Science ®Google Scholar
• Goudsmit E, Hofman MA, Fliers E, Swaab DF. (1990). The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease. Neurobiol. Aging 11:529–536.
   PubMedGoogle Scholar
• Harper DG, Volicer L, Stopa EG, McKee AC, Nitta M, Satlin A. (2005). Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. Am. J. Geriatr. Psychiatry 13:359–368.
   PubMed Web of Science ®Google Scholar
• Hebert R, Dubois MF, Wolfson C, Chambers L, Cohen C. (2001). Factors associated with long-term institutionalization of older people with dementia: Data from the Canadian Study of Health and Aging. J. Gerontol. A Biol. Sci. Med. Sci. 56:M693–M699.
   Google Scholar
• Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S. Yang F, Cole G. (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99–102.
   PubMed Web of Science ®Google Scholar
• Huitron-Resendiz S, Sanchez-Alavez M, Gallegos R, Berg G, Crawford E, Giacchino JL, Games D, Henriksen SJ, Criado JR. (2002). Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res. 928:126–137.
   Google Scholar
• Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT. (1997). APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56:965–973.
   PubMed Web of Science ®Google Scholar
• Irizarry MC, Locascio JJ, Hyman BT. (2001). Beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: Anatomical overlap with transgene expression and static levels with aging. Am. J. Pathol. 158:173–177.
   PubMedGoogle Scholar
• Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG. (2001). Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21:372–381.
   PubMed Web of Science ®Google Scholar
• Klaffke S, Staedt J. (2006). Sundowning and circadian rhythm disorders in dementia. Acta Neurol. Belg. 106:168–175.
   PubMed Web of Science ®Google Scholar
• Lalonde R, Lewis TL, Strazielle C, Kim H, Fukuchi K. (2003). Transgenic mice expressing the betaAPP695SWE mutation: Effects on exploratory activity, anxiety, and motor coordination. Brain Res. 977:38–45.
   PubMed Web of Science ®Google Scholar
• Lee JH, Bliwise DL, Ansari FP, Goldstein FC, Cellar JS, Lah JJ, Levey AI. (2007). Daytime sleepiness and functional impairment in Alzheimer disease. Am. J. Geriatr. Psychiatry 15:620–626.
   PubMed Web of Science ®Google Scholar
• Lee KW, Kim JB, Seo JS, Kim TK, Im JY, Baek IS, Kim KS, Lee JK, Han PL. (2009). Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. J. Neurochem. 108:165–175.
   PubMed Web of Science ®Google Scholar
• Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E. (2001). Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487–1491.
   PubMed Web of Science ®Google Scholar
• Liu RY, Zhou JN, Hoogendijk WJ, van Heerikhuize J, Kamphorst W, Unmehopa UA, Hofman MA, Swaab DF. (2000). Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J. Neuropathol. Exp. Neurol. 59:314–322.
   PubMed Web of Science ®Google Scholar
• Mahlberg R, Kunz D, Sutej I, Kuhl KP, Hellweg R. (2004). Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: An open-label pilot study using actigraphy. J. Clin. Psychopharmacol. 24:456–459.
   PubMedGoogle Scholar
• Martin J, Marler M, Shochat T, Ancoli-Israel S. (2000). Circadian rhythms of agitation in institutionalized patients with Alzheimer's disease. Chronobiol. Int. 17:405–418.
   PubMed Web of Science ®Google Scholar
• Morrissette DA, Parachikova A, Green KN, Laferla FM. (2008). Relevance of transgenic mouse models to human Alzheimer disease. J. Biol. Chem. 284:6033–6037.
   Google Scholar
• Nagels G, Engelborghs S, Vloeberghs E, Van Dam D, Pickut BA, De Deyn PP. (2006). Actigraphic measurement of agitated behaviour in dementia. Int. J. Geriatr. Psychiatry 21:388–393.
   PubMed Web of Science ®Google Scholar
• Ognibene E, Middei S, Daniele S, Adriani W, Ghirardi O, Caprioli A, Laviola G. (2005). Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease. Behav. Brain Res. 156:225–232.
   Google Scholar
• Oosterman JM, van Someren EJ, Vogels RL, Van Hartens B, Scherder EJ. (2009). Fragmentation of the rest-activity rhythm correlates with age-related cognitive deficits. J. Sleep Res. 18:129–135.
   PubMed Web of Science ®Google Scholar
• Pang KC, Miller JP, McAuley JD. (2004). Circadian rhythms in SAMP8: A longitudinal study of the effects of age and experience. Neurobiol. Aging 25:111.
   Google Scholar
• Penev PD, Zee PC, Turek FW. (1997). Quantitative analysis of the age-related fragmentation of hamster 24-h activity rhythms. Am. J. Physiol. 273:R2132–R2137.
   PubMedGoogle Scholar
• Portaluppi F, Touitou Y, Smolensky MH. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25:999–1016.
   PubMed Web of Science ®Google Scholar
• Refinetti R. (2006). Circadian physiology. Boca Raton, FL: CRC Press/Taylor & Francis Group.
   Google Scholar
• Satlin A, Teicher MH, Lieberman HR, Baldessarini RJ, Volicer L, Rheaume Y. (1991). Circadian locomotor activity rhythms in Alzheimer's disease. Neuropsychopharmacology 5:115–126.
   PubMed Web of Science ®Google Scholar
• Scarbrough K, Losee-Olson S, Wallen EP, Turek FW. (1997). Aging and photoperiod affect entrainment and quantitative aspects of locomotor behavior in Syrian hamsters. Am. J. Physiol. 272:R1219–R1225.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. (2001). Alzheimer's disease: Genes, proteins, and therapy. Physiol. Rev. 81:741–766.
   PubMed Web of Science ®Google Scholar
• Skene DJ, Swaab DF. (2003). Melatonin rhythmicity: Effect of age and Alzheimer's disease. Exp. Gerontol. 38:199–206.
   PubMed Web of Science ®Google Scholar
• Sokolove PG, Bushell WN. (1978). The chi square periodogram: Its utility for analysis of circadian rhythms. J. Theor. Biol. 72:131–160.
   PubMed Web of Science ®Google Scholar
• Standaert DG, Lee VM, Greenberg BD, Lowery DE, Trojanowski JQ. (1991). Molecular features of hypothalamic plaques in Alzheimer's disease. Am. J. Pathol. 139:681–691.
   PubMed Web of Science ®Google Scholar
• Stopa EG, Volicer L, Kuo-Leblanc V, Harper D, Lathi D, Tate B, Satlin A. (1999). Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J. Neuropathol. Exp. Neurol. 58:29–39.
   PubMed Web of Science ®Google Scholar
• Swaab DF, Fliers E, Partiman TS. (1985). The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. 342:37–44.
   PubMed Web of Science ®Google Scholar
• Tankersley CG, Irizarry R, Flanders S, Rabold R. (2002). Circadian rhythm variation in activity, body temperature, and heart rate between C3H/HeJ and C57BL/6J inbred strains. J. Appl. Physiol. 92:870–877.
   PubMed Web of Science ®Google Scholar
• Valentinuzzi VS, Scarbrough K, Takahashi JS, Turek FW. (1997). Effects of aging on the circadian rhythm of wheel-running activity in C57BL/6 mice. Am. J. Physiol. 273:R1957–R1964.
   PubMed Web of Science ®Google Scholar
• van de Nes JA, Kamphorst W, Ravid R, Swaab DF. (1998). Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: Amorphic plaques and cytoskeletal changes occur independently. Acta Neuropathol. 96:129–138.
   Google Scholar
• van Someren EJ, Swaab DF, Colenda CC, Cohen W, McCall WV, Rosenquist PB. (1999). Bright light therapy: Improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol. Int. 16:505–518.
   PubMed Web of Science ®Google Scholar
• Vloeberghs E, Van Dam D, Engelborghs S, Nagels G, Staufenbiel M, De Deyn P. (2004). Altered circadian locomotor activity in APP23 mice: A model for BPSD disturbances. Eur. J. Neurosci. 20:2757–2766.
   PubMed Web of Science ®Google Scholar
• Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A. (2001). Sundowning and circadian rhythms in Alzheimer's disease. Am. J. Psychiatry 158:704–711.
   PubMed Web of Science ®Google Scholar
• Wisor JP, Edgar DM, Yesavage J, Ryan HS, McCormick CM, Lapustea N, Murphy GM. (2005). Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: A role for cholinergic transmission. Neuroscience 131:375–385.
   PubMed Web of Science ®Google Scholar
• Witting W, Kwa IH, Eikelenboom P, Mirmiran M, Swaab DF. (1990). Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol. Psychiatry 27:563–572.
   PubMed Web of Science ®Google Scholar
• Wu YH, Zhou JN, van Heerikhuize J, Jockers R, Swaab DF. (2007). Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease. Neurobiol. Aging 28:1239–1247.
   PubMed Web of Science ®Google Scholar
• Yuede CM, Zimmerman SD, Dong H, Kling MJ, Bero AW, Holtzman DM, Timson BF, Csernansky JG. (2009). Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease. Neurobiol. Dis. 35:426–432.
   PubMed Web of Science ®Google Scholar
• Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, Landreth GE, Vinters HV, Tontonoz P. (2007). Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc. Natl. Acad. Sci. USA 104:10601–10606.
   PubMed Web of Science ®Google Scholar
• Zhuo JM, Prakasam A, Murray ME, Zhang, HY, Baxter MG, Sambamurti K, Nicolle MM. (2008). An increase in Abeta42 in the prefrontal cortex is associated with a reversal-learning impairment in Alzheimer's disease model Tg2576 APPsw mice. Curr. Alzheimer Res. 5:385–391.
   Google Scholar